1579 Results

People

  1. Cheung
    Cheung
  2. Wolchok
    Wolchok
  3. Postow
    Postow
  4. Hellmann
    Hellmann
  5. Adusumilli
    Adusumilli
  6. Old
    Old
  7. Livingston
    Livingston
  8. Motzer
    Motzer
  9. Slovin
    Slovin
  10. Houghton
    Houghton

Groups

  1. Department of Medicine (882)
  2. Solid Tumor Oncology Division (646)
  3. GSK Faculty (409)
  4. Hematologic Malignancies, Division of (373)
  5. Sloan Kettering Institute Postdocs (252)
  6. Melanoma and Immunotherapeutics Service (227)
  7. Center for Hematologic Malignancies (221)
  8. Surgery (221)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (191)
  10. Melanoma Disease Management Team (186)
  1. "immunotherapy"
Formats
  1. Journal Article (1126)
  2. Review (243)
  3. Editorial (60)
  4. Meeting Abstract (57)
  5. Book Section (30)
  6. Guidelines (28)
  7. Research Letter (14)
  8. Conference Paper (9)
  9. Correspondence (7)
  10. Miscellaneous (5)
Groups
  1. Department of Medicine (882)
  2. Solid Tumor Oncology Division (646)
  3. GSK Faculty (409)
  4. Hematologic Malignancies, Division of (373)
  5. Sloan Kettering Institute Postdocs (252)
  6. Melanoma and Immunotherapeutics Service (227)

More Groups

People
  1. Jedd Wolchok (107)
  2. Nai-Kong Cheung (71)
  3. Michael Postow (67)
  4. Matthew Hellmann (53)
  5. Prasad Adusumilli (39)
  6. Michel Sadelain (36)

More People

Years
  1. 2025 (69)
  2. 2024 (160)
  3. 2023 (135)
  4. 2022 (134)
  5. 2021 (129)
  6. 2020 (102)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (117)
  2. Journal of Thoracic Oncology (55)
  3. Clinical Cancer Research (41)
  4. Annals of Oncology (35)
  5. Cancer Immunology, Immunotherapy (29)
  6. Cancer (28)

More Publications

Publishers
  1. Elsevier Inc. (242)
  2. Biomed Central Ltd (139)
  3. Springer (103)
  4. Wiley Blackwell (83)
  5. American Association for Cancer Research (69)
  6. Oxford University Press (67)

More Publishers

Results (1579)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predictive biomarkers in advanced renal cell carcinoma
    Book Section

    Shinder, B. M.; Kronstedt, S.; Hakimi, A. A.
    In McKay, R. R.; Singer, E. A. (Eds.) Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma (2023)

    Fulltext@MSK | Save
  • Nivolumab in salivary gland cancers: Confronting the challenges of unlocking the therapeutic benefits of immunotherapy for rare diseases
    Editorial

    Desilets, A.; Ho, A. L.
    BMJ Oncology (2023)

    Fulltext@MSK | Save
  • Diabetes care in the oncologic population
    Journal Article

    Presswala, L. S.; Farooki, A.; Flory, J.
    Contemporary Endocrinology (2023)

    Fulltext@MSK | Save
  • Racial disparity in the utilization of immunotherapy for advanced prostate cancer
    Journal Article

    Mouzannar, A.; Delgado, J.; Kwon, D.; Atluri, V. S.; Mason, M. M.; Prakash, N. S.; Zhao, W.; Nahar, B.; Swain, S.; Punnen, S.; more...
    Journal of the National Medical Association (2023)

    Fulltext@MSK | Save
  • Unique characteristics of the tumor immune microenvironment in young patients with metastatic colorectal cancer
    Journal Article

    Griffith, B. D.; Lazarus, J.; McGue, J.; Krishnan, S.; D’Angelica, M. I.; Shia, J.; Dobrosotskaya, I.; Shi, J.; Edwards, J.; Rao, A.; more...
    Frontiers in Immunology (2023)

    Fulltext@MSK | Save
  • Virus-specific T-cells from third party or transplant donors for treatment of EBV lymphoproliferative diseases arising post hematopoietic cell or solid organ transplantation
    Review

    O’Reilly, R. J.; Prockop, S.; Oved, J. H.
    Frontiers in Immunology (2023)

    Fulltext@MSK | Save
  • Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
    Journal Article

    Maura, F.; Boyle, E. M.; Coffey, D.; Maclachlan, K.; Gagler, D.; Diamond, B.; Ghamlouch, H.; Blaney, P.; Ziccheddu, B.; Cirrincione, A.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Safety of immunomodulatory systemic therapies used in the management of immune-related cutaneous adverse events
    Review

    Gu, S. L.; Nath, S.; Markova, A.
    Pharmaceuticals (2023)

    Fulltext@MSK | Save
  • Bleeding in critically ill children with malignancy or hematopoietic cell transplant: A single-center prospective cohort study
    Journal Article

    Levasseur, J.; Fikse, L.; Mauguen, A.; Killinger, J. S.; Karam, O.; Nellis, M. E.
    Pediatric Critical Care Medicine (2023)

    Fulltext@MSK | Save
  • Evaluating immune-related adverse events using PRO-CTCAE in a phase II study of ipilimumab for hormone-sensitive prostate cancer
    Journal Article

    Vargas P. de Almeida, D.; Anderson, J. M.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Abida, W.; Cohn, E. D.; Baser, R. E.; Scher, H. I.; Autio, K. A.
    Journal of Immunotherapy and Precision Oncology (2023)

    Fulltext@MSK | Save